DEA Greenlights Drug Imports: Almac's Bid for Controlled Meds
Published Date: 4/28/2025
Notice
Summary
Almac Clinical Services, Inc. wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs for medical and research use. If approved, it could speed up access to important medicines without extra costs or delays.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Company Applies to Import Controlled Drugs
Almac Clinical Services, Inc. has applied to be registered as an importer of basic classes of controlled substances. If approved, the company would be allowed to bring in those drugs for medical and research use, which could speed up access to important medicines without extra costs or delays.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in